EOM 4a: Pain Intensity Quantified
Measure Description:
Percentage of patient visits who have a diagnosis of cancer and are currently receiving chemotherapy (excludes oral) or radiation therapy, in which pain intensity is quantified.
Relevance to Value Based Care:
Inadequate cancer pain management is widely prevalent, harmful to the patient, and costly.
Denominator:
Denominator 1: All EM visits with cancer diagnosis receiving at least 2 IV chemotherapy admins on or within 30 days prior or 30 days after EM visit.
Denominator 2: All radiation treatment visits (77427, 77431, 77432, 77435) visits with cancer diagnosis receiving radiation therapy.
Numerator:
Numerator 1: Patient visits in which pain intensity is quantified for patients undergoing IV chemotherapy. (Patients undergoing oral chemotherapy are not included)
Numerator 2: Patient visits in which pain intensity is quantified for patients undergoing radiation therapy.
Numerator Instructions: Pain intensity should be quantified using a standard instrument, such as a 0-10 numerical rating scale, visual analog scale, a categorical scale, or pictorial scale.
Exclusions: None.
RESOURCES